Does the Use of Bispectral Index Reduce the Oxidative Stress in Endoscopic Retrograde Cholangiopancreatography?
Effects of Bispectral Index on Oxidative Stress
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
Objective Endoscopic Retrograde Cholangiopancreatography (ERCP) is performed for resolving cholestasis by sphincterotomy and/or stone extraction and is done with deep sedation or general anesthesia. The investigators primary outcome was to evaluate the effects of the depth of anesthesia on oxidative stres provided via Bispectral Index (BIS) monitorisation during the ERCP procedure by analyzing the biochemical parameters. And their secondary outcome was the effects of anesthesia depth on propofol consumption and postoperative sedation status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 27, 2016
CompletedFirst Posted
Study publicly available on registry
June 8, 2016
CompletedJanuary 24, 2017
May 1, 2016
11 months
May 27, 2016
January 23, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effects of BIS on oxidative stress
The investigators aimed to investigate the effects of anesthesia with monitoring the depth of anesthesia using BIS on oxidative stres by measuring the total oxidant status (TAS) and total antioxidant status (TOS) , propofol consumption, and postoperative recovery during ERCP procedures in this study.
one day
Study Arms (2)
Group R (Ramsey)=25 patients
ACTIVE COMPARATORPropofol infusion was administered to provide Ramsey Sedation Scale 3-4 in Group R
Group B (BIS)=25 patients
EXPERIMENTALPropofol infusion was given to maintain the Bispectral index monitorisation (BIS) levels between 60 and 85 in Group B.
Interventions
Standard monitoring was performed with electrocardiography, pulse oximetry and non invasive blood pressure. Additionally, Bispectral index (Aspect Medical Systems, Natica, MA) electrodes were connected to Group B patients
Propofol administration was done to keep the Ramsey Sedation scale of 3 or 4
Eligibility Criteria
You may qualify if:
- Patients with American Society of Anesthesiologists physical status I-II
- Patients undergoing ERCP procedures
You may not qualify if:
- uncontrolled comorbidities (hypertension, diabetes mellitus, kidney-liver failure)
- difficulty in communication (language problems, such as deafness)
- who are allergic to the drugs used
- pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 27, 2016
First Posted
June 8, 2016
Study Start
May 1, 2014
Primary Completion
April 1, 2015
Study Completion
October 1, 2015
Last Updated
January 24, 2017
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share data